Header Logo

Connection

Christopher Crank to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Christopher Crank has written about Cost-Benefit Analysis.
Christopher Crank
Connection Strength
0.083
Cost-Benefit Analysis
  1. Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome. J Oncol Pharm Pract. 2011 Sep; 17(3):147-54.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.